Inactive/Delisted stock
Cardio Diagnostics Stock (NASDAQ:CDIO)
Previous Close
$4.52
52W Range
$3.40 - $53.10
50D Avg
$8.79
200D Avg
$12.53
Market Cap
$8.28M
Avg Vol (3M)
$54.16K
Beta
3.05
Div Yield
-
CDIO Company Profile
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.